ARA-290 Supplements
Neuroprotection and Tissue Repair via Innate Repair Receptor (IRR) Activation
Key Insight
ARA-290 serves as a non-erythropoietic 'master switch' that reprograms the cellular environment from a pro-inflammatory state to a regenerative phenotype by selectively targeting the heteromeric Innate Repair Receptor.
Pinned Admin
A peptide is not a solo act. When ARA-290 (Cibinetide) enters your system, it doesn't politely wait for conditions to be perfect — it starts activating pathways, demanding cofactors, and burning through substrates at a rate your baseline nutrition almost certainly can't support.
Most protocols fail not because the peptide doesn't work, but because the body runs out of the raw materials it needs to keep up. The result? Stalls, side effects, and diminishing returns that get blamed on the compound when the real bottleneck was a missing mineral or an overwhelmed enzyme.
This companion guide maps exactly what ARA-290 (Cibinetide) demands from your biochemistry — pathway by pathway — and builds a targeted supplement stack to meet those demands. Not a generic multivitamin checklist. Not guesswork. A precise, evidence-graded protocol designed to let the peptide do what it was engineered to do.
Read it once to understand the “why.” Bookmark the Quick Reference at the bottom for the “what.”
Each pathway your peptide activates creates its own set of demands. Here's what your body needs to keep up.
IRR Activation & Master Signaling
Selectively binds the tissue-protective Innate Repair Receptor (EPOR/CD131) to initiate anti-inflammatory and regenerative cascades.
Enables membrane fluidity and stable assembly of the IRR complex.
IRR subunits must migrate and associate within the lipid bilayer for activation.
Stay Ahead of the Research
Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.
No spam. Unsubscribe anytime. Clinical rigor, always.